Page 6 - Phasei Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Dr Spira on the Evaluation of Fianlimab Plus Cemiplimab in Advanced Melanoma

Dr Spira on the Evaluation of Fianlimab Plus Cemiplimab in Advanced Melanoma
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

United statesAlexanderi spiraPhasei programJohns hopkins school of medicineVirginia cancer specialists research instituteJohns hopkins school

Marula Mining Plc - Interest Secured in the NyoriGreen Graphite Project in Tanzania

Marula Mining Plc - Interest Secured in the NyoriGreen Graphite Project in Tanzania
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

South africaUnited kingdomManyara regionCity ofWestern capeBaden wübergKinyanjui mumbiCharles goodfellow duncan vaseyTim blythe megan rayJason brewerMurray ludovico lazzarettiPhasei programCompany boardMarula miningLondon stock exchangeMarula mining plc

Dr Moore on the Design of a Phase 1/2 Study of Ubamatamab in Ovarian Cancer

Kathleen N. Moore, MD, MS, discusses the design of the ongoing, first-in-human, phase 1/2 study of the MUC16- and CD3-targeted bispecific antibody ubamatamab alone or in combination with cemiplimab in patients with recurrent ovarian cancer.

United statesUniversity of oklahomaKathleenn mooreClinical researchPhasei programUniversity of oklahoma college medicineStephenson cancer centerOncology centerGynecologic oncologyOklahoma collegeExcellence project optimusOvarian cancerOnclive tv

CAR T-Cell Therapy Innovations Unfold Across the Spectrum of Cancer Care

Martin E. Gutierrez, MD, and Lori A. Leslie, MD, discuss common barriers to implementing CAR T-cell therapy programs, early successes that John Theurer Cancer Center in New Jersey has seen with outpatient CAR T-cell therapy administration, and developments on the horizon for administering this approach in solid tumors

New jerseyUnited statesHackensack university medical centerMartine gutierrezGloria leslieHackensack meridian school of medicinePhasei diseases groupJohn theurer cancer centerThoracic gastrointestinal oncology programDrug discovery phasei programThoracic oncology at john theurer cancer centerDepartment of oncologyLymphoma division john theurer cancer centerPhasei programThoracic oncologyHackensack meridian school

Early Data Signal Response With CBX-12 in Advanced or Metastatic Solid Tumors

Funda Meric-Bernstam, MD, discusses the safety of CBX-12 and exploring dosage of the agent.

United statesNellieb connallyUniversity of texas md anderson cancer centerPhasei programInstitute for personalized cancer therapyDepartment of investigational cancer therapeuticsFunda meric bernstamInvestigational cancer therapeuticsPersonalized cancer therapyBreast cancerCancer centerCbx 12Patients with advanced or metastatic solid tumorsThe university of texas md anderson cancer center